Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Karoo Health Launches Proprietary Technology Platform Kohere.ai to Supercharge Its Cardiac Value-based Care Model


AI-enriched platform transforms disparate data into actionable insights for care providers and partners, boosts patient engagement and access to care for improved outcomes at lower cost

ALBUQUERQUE, N.M., April 18, 2024 /PRNewswire/ -- Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with published results, today launched Kohere.ai, its proprietary cloud-based platform that augments the company's proven model of care (MoC) for cardiovascular healthcare providers, payers, and patients. The Kohere.ai platform launch and 2024 roadmap are composed of the following modules:

Kohere.ai empowers Karoo Health's MoC expansion across partner types, regions, and patients, enabling VBC for the right cardiac patients at the right time, driving optimal outcomes and reducing cost of care.

A recent proof of concept conducted by Karoo Health with participating providers continues to reveal that 89% of eligible patients are converted to the Karoo Health's MoC, a 99% digital engagement rate is being achieved among enrolled patients, and 23% of patients are being diverted from at least one unnecessary ED visit. With industry-leading results already demonstrated, the implementation of Kohere.ai will supercharge Karoo Health's MoC, allowing more patients to experience better outcomes and lower cost of care.

"We're further differentiating ourselves by using technology to supercharge our cardiac VBC model," said Karoo Health CEO and Cofounder Ian Koons. "Instead of building software and then trying to retrofit a care model around it, our initial goal was to perfect a value-based Model of Care that truly delivers results, and then build cutting-edge technology to amplify its strengths. Kohere.ai does this, including AI components available now and the ability to integrate future AI at scale in our roadmap."

An example of the AI capabilities in Kohere.ai is risk stratification, which analyzes vast amounts of patient data to identify patterns and predictors of cardiac health risks. Kohere.ai uses these findings to identify patients at higher risk of adverse health outcomes, allowing providers to tailor interventions.

Seamlessly integrating dedicated on-site and virtual care teams with its Kohere.ai proprietary technology platform in a unique wraparound care model, Karoo Health is the only operational cardiac VBC enabler with published results, improving patient outcomes and lowering the cost of treating cardiovascular disease. Karoo Health is a pioneer in the value-based healthcare services market, which is estimated at USD $1.63 trillion in 2024 and is expected to reach USD $3.77 trillion by 2029, growing at a CAGR of more than 18% during the forecast period.

About Karoo Health

Heart disease is currently the leading cause of death in the United States, with one person dying every 33 seconds due to cardiovascular illness. Employing an exclusive mix of specialized care teams and proprietary technology grounded in value-based principles, Karoo Health enables cardiology providers, networks, health plans, and at-risk primary care groups to seamlessly transition to, and succeed in, value-based care, and excel in outcomes-driven initiatives crucially required within the cardiac domain. For more information, visit the company at www.karoohealth.com or connect with them on LinkedIn.

SOURCE Karoo Health


These press releases may also interest you

at 10:33
Chemres and Chemres Trinity, part of the Benvic Group for over two years, announce a full transition to the Benvic name. As of May 1st, 2024, these companies will operate as Benvic....

at 10:30
Enteral Feeding Devices Market in terms of revenue was estimated to be worth $4.0 billion in 2024 and is poised to reach $5.6 billion by 2029, growing at a CAGR of 6.2% from 2024 to 2029 according to a new report by MarketsandMarketstm. The global...

at 10:30
The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population. The trend is set to create new opportunities for the market, leading to a projected CAGR...

at 10:30
Encoda, a leader in healthcare reimbursement technology, has released new research findings that show the intricate balance between financial sustainability and patient care....

at 10:30
The fourth annual Hearing Loss in the Workplace survey1, conducted by TruHearing, the market leader in hearing healthcare benefits, revealed that interest in hearing benefits has drastically increased among working adults....

at 10:21
Starting today, the first one million seniors who successfully applied to the Canadian Dental Care Plan (CDCP) and have a May coverage start date in their welcome package, can now receive the dental care they need. Also as of today, potentially...



News published on and distributed by: